From Name:
From Email:
To Name:
To Email:

Optional Message:


Expert Panel: Clinical Need for Bioresorbable Technology Remains

from Healio

Although disappointing data and safety issues hampered the introduction of bioresorbable vascular scaffolds (BVS), improvements in technology and implantation techniques as well as optimized patient selection and post-procedural management may help forge a place for these devices in percutaneous coronary intervention (PCI) procedures. "Because of the considerable amount of information, variability in practice and the number of statements being made regarding BVS, we convened a panel of experts to draft a consensus statement on the current strengths and limitations of BVS and what the future may hold," lead consensus statement author Sripal Bangalore, MD, MHA, director of research, cardiac catheterization laboratory, director of the Cardiovascular Outcomes Group in the Leon H. Charney Division of Cardiology and associate professor of medicine at New York University School of Medicine, told Cardiology Today's Intervention. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063